Blood test vs. biopsy: can a simple draw replace tissue sampling for lung cancer mutations?
NCT ID NCT03265496
First seen Mar 24, 2026 · Last updated May 24, 2026 · Updated 8 times
Summary
This study looked at 21 people with advanced lung cancer to see if a blood test (liquid biopsy) could find EGFR gene mutations as accurately as a standard tumor biopsy. Researchers compared results from three different lab methods. The goal was to improve how doctors detect these mutations, which can guide treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHRU Lille
Lille, 59037, France
-
Centre Oscar Lambret
Lille, 59020, France
Conditions
Explore the condition pages connected to this study.